The immunohistochemical profile of basal cell nevus syndrome–associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis

Clinical Oral Investigations (2021)Cite this article

Abstract

Objectives

To provide a systematic review of the literature on studies comparing the immunoprofile of nevoid basal cell carcinoma syndrome (BCNS)–associated and sporadic odontogenic keratocysts (OKCs), in order to identify markers that could accurately distinguish the two OKC subtypes.

Materials and methods

We searched MEDLINE/Pubmed, Web of Science, EMBASE via OVID, and grey literature for publications until December 28th, 2019, that compared the immunohistochemical expression of the two OKC subtypes. The studies were qualitatively assessed using the Critical Appraisal Tool for Case Series (Joana Briggs Institute). Sensitivity and specificity, positive and negative likelihood ratio, diagnostic odds ratio and area under the curve, and pooled estimates were calculated, using a random-effects model.

Results

Seventy-one studies were qualitatively analyzed; 61 markers were evaluated in one study and 32 in ≥ 2 studies. Twenty-five studies reported differential expression of 29 markers in the form of higher number of positive cells or greater staining intensity usually in BCNS-associated OKCs. Meta-analysis for bcl-2, Cyclin D1, CD56, CK18, p53, and PCNA showed that none of those markers is distinguishable between BCNS-associated and sporadic OKCs, in a 95% confidence interval. The risk of bias was high in 34 studies, moderate in 22, and low in 15.

Conclusions

The present systematic review and meta-analysis uncovered that, although several immunohistochemical markers might characterize the OKC phenotype, they cannot discriminate between the BCNS-associated and sporadic OKCs.

Clinical relevance

This study highlighted the requirement for additional screening for markers by immunohistochemistry, preferentially coupled to alternative diagnostic applications such as genomics technologies.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, Bale AE, Bale SJ (1997) Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69:299–308

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Manfredi M, Vescovi P, Bonanini M, Porter S (2004) Nevoid basal cell carcinoma syndrome: a review of the literature. Int J Oral Maxillofac Surg 33:117–124. https://doi.org/10.1054/ijom.2003.0435

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Witmanowski H, Szychta P, Blochowiak K, Jundzill A, Czajkowski R (2017) Basal cell nevus syndrome (Gorlin-Goltz syndrome): genetic predisposition, clinical picture and treatment. Postepy dermatologii i alergologii 34:381–387. https://doi.org/10.5114/ada.2017.69323

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Gorojankina T (2016) Hedgehog signaling pathway: a novel model and molecular mechanisms of signal transduction. Cell Mol Life Sci 73:1317–1332. https://doi.org/10.1007/s00018-015-2127-4

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Bresler SC, Padwa BL, Granter SR (2016) Nevoid basal cell carcinoma syndrome (Gorlin Syndrome). Head and neck pathology 10:119–124. https://doi.org/10.1007/s12105-016-0706-9

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Fujii K, Ohashi H, Suzuki M, Hatsuse H, Shiohama T, Uchikawa H, Miyashita T (2013) Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome. Familial Cancer 12:611–614. https://doi.org/10.1007/s10689-013-9623-1

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Yamamoto T, Ichioka H, Yamamoto K, Kanamuraa N, Sumitomo S, Shikimori M, Mori M (2011) Nevoid basal cell carcinoma syndrome: clinical features and implications of development of basal cell carcinoma in skin and keratocystic odontogenic tumor in jaw and their gene expressions. Asian J Oral Maxillofac Surg 23:105–112. https://doi.org/10.1016/j.ajoms.2011.01.003

    Article  Google Scholar 

  8. 8.

    Karhade DS, Afshar S, Padwa BL (2019) What is the prevalence of undiagnosed nevoid basal cell carcinoma syndrome in children with an odontogenic keratocyst? J Oral Maxillofac Surg 77:1389–1391. https://doi.org/10.1016/j.joms.2019.01.045

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Antonoglou GN, Sandor GK, Koidou VP, Papageorgiou SN (2014) Non-syndromic and syndromic keratocystic odontogenic tumors: systematic review and meta-analysis of recurrences. J Craniomaxillofac Surg 42:e364–e371. https://doi.org/10.1016/j.jcms.2014.03.020

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Woolgar JA, Rippin JW, Browne RM (1987) A comparative study of the clinical and histological features of recurrent and non-recurrent odontogenic keratocysts. J Oral Pathol 16:124–128. https://doi.org/10.1111/j.1600-0714.1987.tb01478.x

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Bree AF, Shah MR, Group BC (2011) Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A 155A:2091–2097. https://doi.org/10.1002/ajmg.a.34128

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Raab SS (2000) The cost-effectiveness of immunohistochemistry. Arch Pathol Lab Med 124:1185–1191

    PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    el Murtadi A, Grehan D, Toner M, McCartan BE (1996) Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:217–220

    PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Li TJ, Browne RM, Matthews JB (1995) Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med 24:221–226

    PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Kimi K, Kumamoto H, Ooya K, Motegi K (2001) Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med 30:434–442

    PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Lo Muziol L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, De Rosa G (1999) Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 78:1345–1353. https://doi.org/10.1177/00220345990780070901

    Article  Google Scholar 

  17. 17.

    Vera-Sirera B, Forner-Navarro L, Vera-Sempere F (2015) Differential expression of Cyclin D1 in keratin-producing odontogenic cysts. Med Oral Patol Oral Cir Bucal 20:e59–e65

    PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Kolar Z, Geierova M, Bouchal J, Pazdera J, Zboril V, Tvrdy P (2006) Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med 35:75–80

    PubMed  Article  PubMed Central  Google Scholar 

  19. 19.

    Leonardi R, Matthews JB, Loreto C, Musumeci G, Campisi G, Lo Muzio L, dos Santos JN, Pastorino L, Bufo P, Pannone G (2013) Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions. Histol Histopathol 28:1175–1184

    PubMed  PubMed Central  Google Scholar 

  20. 20.

    Hoyos Cadavid AM, Kaminagakura E, Rodrigues MFSD, Pinto CAL, Teshima THN, Alves FA (2019) Immunohistochemical evaluation of Sonic Hedgehog signaling pathway proteins (Shh, Ptch1, Ptch2, Smo, Gli1, Gli2, and Gli3) in sporadic and syndromic odontogenic keratocysts. Clin Oral Investig 23:153–159

    PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K (2004) PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 33:584–592

    PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Zedan W, Robinson PA, Markham AF, High AS (2001) Expression of the sonic hedgehog receptor 'PATCHED' in basal cell carcinomas and odontogenic keratocysts. J Pathol 194:473–477

    PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 339:b2700. https://doi.org/10.1136/bmj.b2700

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj 350:g7647. https://doi.org/10.1136/bmj.g7647

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L (2012) The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Systematic reviews 1:2. https://doi.org/10.1186/2046-4053-1-2

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Braschi B, Denny P, Gray K, Jones T, Seal R, Tweedie S, Yates B, Bruford E (2019) Genenames.org: the HGNC and VGNC resources in 2019. Nucleic Acids Res 47:D786–D792. https://doi.org/10.1093/nar/gky930

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    HGNC Database, HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom, www.genenames.org.

  28. 28.

    Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R et al (2017) Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) Joanna Briggs Institute Reviewer's. The Joanna Briggs Institute, Manual

    Google Scholar 

  29. 29.

    Review Manager (RevMan) [Computer program]. Version 5.4, The Cochrane Collaboration, 2020.

  30. 30.

    Heatley MK (2008) Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis. Histopathology 52:267–276. https://doi.org/10.1111/j.1365-2559.2007.02824.x

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Wiggers JK, Ruys AT, Groot Koerkamp B, Beuers U, ten Kate FJ, van Gulik TM (2014) Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Gastroenterol Hepatol 29:1582–1594. https://doi.org/10.1111/jgh.12620

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. https://doi.org/10.1186/1471-2288-6-31

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Raffone A, Travaglino A, Saccone G, Campanino MR, Mollo A, De Placido G, Insabato L, Zullo F (2019) Loss of PTEN expression as diagnostic marker of endometrial precancer: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 98:275–286. https://doi.org/10.1111/aogs.13513

    Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Yerushalmy J (1947) Statistical problems in assessing methods of medical diagnosis, with special reference to X-ray techniques. Public Health Rep 62:1432–1449

    PubMed  Article  PubMed Central  Google Scholar 

  35. 35.

    Swets JA (1973) The relative operating characteristic in psychology: a technique for isolating effects of response bias finds wide use in the study of perception and cognition. Science 182:990–1000. https://doi.org/10.1126/science.182.4116.990

    Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135. https://doi.org/10.1016/s0895-4356(03)00177-x

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2

    Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129. https://doi.org/10.2307/3001666

    Article  Google Scholar 

  39. 39.

    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186

    Article  Google Scholar 

  40. 40.

    Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316. https://doi.org/10.1002/sim.4780121403

    Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283–298. https://doi.org/10.1016/s0001-2998(78)80014-2

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Balduzzi S, Rucker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid-Based Ment Health 22:153–160. https://doi.org/10.1136/ebmental-2019-300117

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Alur J, Narayan TV, Mohanty L, Shenoy S, Jamadar S, Shetty S (2014) Ki-67 and p53 expression in solitary sporadic, syndrome associated and recurrent keratocystic odontogenic tumor. J Oral Maxillofac Pathol 18:S21–S25. https://doi.org/10.4103/0973-029x.141330

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Amm HM, Casimir MD, Clark DB, Sohn P, MacDougall M (2014) Matrix metalloproteinase expression in keratocystic odontogenic tumors and primary cells. Connect Tissue Res 55:97–101

    PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Amorim RFB, Godoy GP, Galvao HC, Souza LB, Freitas RA (2004) Immunohistochemical assessment of extracellular matrix components in syndrome and non-syndrome odontogenic keratocysts. Oral Dis 10:265–270. https://doi.org/10.1111/j.1601-0825.2004.01023.x

    Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Awni S, Conn B (2017) Decompression of keratocystic odontogenic tumors leading to increased fibrosis, but without any change in epithelial proliferation. Oral Surg Oral Med Oral Pathol Oral Radiol 123:634–644

    PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Ba K, Li X, Wang H, Liu Y, Zheng G, Yang Z, Li M, Shimizutani K, Koseki T (2010) Correlation between imaging features and epithelial cell proliferation in keratocystic odontogenic tumour. Dento maxillo facial Radiol 39:368–374. https://doi.org/10.1259/dmfr/27538271

    Article  Google Scholar 

  48. 48.

    Barreto DC, Bale AE, De Marco L, Gomez RS (2002) Immunolocalization of PTCH protein in odontogenic cysts and tumors. J Dent Res 81:757–760

    PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Cairns L, Naidu A, Robinson CM, Sloan P, Wright JM, Hunter KD (2010) CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions. Histopathology 57:544–548

    PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    Carvalhais JN, De Aguiar MCF, De Araujo VC, De Araujo NS, Gomez RS (1999) p53 and MDM2 expression in odontogenic cysts and tumours. Oral Dis 5:218–222

    PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Cavalcante RB, Pereira KM, Nonaka CF, Nogueira RL, de Souza LB (2008) Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:99–105. https://doi.org/10.1016/j.tripleo.2007.12.028

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Chang CH, Wu YC, Wu YH, Sun A, Cheng SJ, Chen HM (2017) Significant association of inflammation grade with the number of Langerhans cells in odontogenic keratocysts. J Formos Med Assoc 116:798–805

    PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Chang CH, Wu YC, Wu YH, Sun A, Cheng SJ, Li HP (2017) Langerhans cells in 60 odontogenic keratocysts. J Dent Sci 12:283–290. https://doi.org/10.1016/j.jds.2017.04.001

    Article  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Cota JE, Spadigam A, Dhupar A (2019) Detection of type VII collagen in odontogenic keratocyst: an immunohistochemical study. J Clin Exp Dent 11:e310–e314. https://doi.org/10.4317/jced.54946

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    de Brito Monteiro BV, Cavalcante RB, Maia Nogueira RL, da Costa Miguel MC, Weege Nonaka CF, da Silveira EJ (2015) Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol 120:52–57

    PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    de Oliveira RG, Costa A, Meurer MI, Vieira DSC, Rivero ERC (2014) Immunohistochemical analysis of matrix metalloproteinases (1, 2, and 9), Ki-67, and myofibroblasts in keratocystic odontogenic tumors and pericoronal follicles. J Oral Pathol Med 43:282–288

    Article  Google Scholar 

  57. 57.

    Diniz MG, Gomes CC, de Castro WH, Guimaraes AL, De Paula AM, Amm H, Ren C, MacDougall M, Gomez RS (2012) miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors. Cell Oncol (Dordr) 35:285–291. https://doi.org/10.1007/s13402-012-0087-3

    Article  Google Scholar 

  58. 58.

    Doll C, Dauter K, Johrens K, Hartwig S, Voss JO, Klein M, Heiland M, Raguse JD (2018) Clinical characteristics and immunohistochemical analysis of p53, Ki-67 and Cyclin D1 in 80 odontogenic keratocysts. J Stomatol Oral Maxillofac Surg 119:359–364

    PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    dos Santos JN, Oliveira GQV, Gurgel CAS, de Souza RO, Sales CBS, Neto A, Ramos EAG (2009) Altered expression of cytokeratins in primary, recurrent and syndrome keratocystic odontogenic tumors. J Mol Histol 40:269–275. https://doi.org/10.1007/s10735-009-9238-x

    Article  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Figueroa A, Correnti M, Avila M, Andea A, DeVilliers P, Rivera H (2010) Keratocystic odontogenic tumor associated with nevoid basal cell carcinoma syndrome: similar behavior to sporadic type? Otolaryngol Head Neck Surg 142:179–183

    PubMed  Article  PubMed Central  Google Scholar 

  61. 61.

    Foschini MP, Cocchi R, Marucci G, Pennesi MG, Magrini E, Ligorio C, Lombardini F, Tosi AL, Marchetti C (2006) High DeltaN p63 isoform expression favours recurrences in odontogenic keratocyst-odontogenic keratocystic tumour. Int J Oral Maxillofac Surg 35:673–675

    PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Gonzalez Moles MA, Mosqueda-Taylor A, Esteban F, Gil-Montoya JA, Diaz-Franco MA, Delgado M, Munoz M (2008) Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 44:1127–1133

    PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Gonzalez-Moles MA, Mosqueda-Taylor A, Delgado-Rodriguez M, Martinez-Mata G, Gil-Montoya JA, Diaz-Franco MA, Bravo-Perez JJ, N MG (2006) Analysis of p53 protein by PAb240, Ki-67 expression and human papillomavirus DNA detection in different types of odontogenic keratocyst. Anticancer Res 26:175–181

    PubMed  PubMed Central  Google Scholar 

  64. 64.

    Gratzinger D, Salama ME, Poh CF, Rouse RV (2008) Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression. J Oral Pathol Med 37:177–184

    PubMed  Article  PubMed Central  Google Scholar 

  65. 65.

    Gurgel CAS, Buim MEC, Carvalho KC, Sales CBS, Reis MG, de Souza RO, Valverde LD, de Azevedo RA, dos Santos JN, Soares FA, Ramos EAG (2014) Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma. J Oral Pathol Med 43:619–626. https://doi.org/10.1111/jop.12180

    Article  PubMed  PubMed Central  Google Scholar 

  66. 66.

    Gurgel CA, Ramos EAG, Azevedo RA, Sarmento VA, Da Silva Carvalho AM, Dos Santos JN (2008) Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study. J Mol Histol 39:311–316

    PubMed  Article  PubMed Central  Google Scholar 

  67. 67.

    Silva Gurgel CA, Ramos EAG, Melo LA, Schlaepfer CB, de Souza RO, Oliveira MC, dos Santos JN (2010) Immunolocalisation of laminin-1 in keratocystic odontogenic tumors. Acta Histochem 112:624–629. https://doi.org/10.1016/j.acthis.2009.06.006

    Article  PubMed  PubMed Central  Google Scholar 

  68. 68.

    Hakim SG, Kosmehl H, Sieg P, Trenkle T, Jacobsen HC, Benedek GA, Ribbat J, Driemel O (2011) Altered expression of cell-cell adhesion molecules beta-catenin/E-cadherin and related Wnt-signaling pathway in sporadic and syndromal keratocystic odontogenic tumors. Clin Oral Investig 15:321–328

    PubMed  Article  PubMed Central  Google Scholar 

  69. 69.

    High AS, Robinson PA, Klein CE (1993) Discrimination of parakeratinised odontogenic keratocysts from other odontogenic and non-odontogenic cyst types by expression of a 38kd cell-surface glycoprotein. J Oral Pathol Med 22:363–367. https://doi.org/10.1111/j.1600-0714.1993.tb01090.x

    Article  PubMed  PubMed Central  Google Scholar 

  70. 70.

    Ibrahim N, Nazimi AJ, Ajura AJ, Nordin R, Latiff ZA, Ramli R (2016) The clinical features and expression of bcl-2, Cyclin D1, p53, and proliferating cell nuclear antigen in syndromic and nonsyndromic keratocystic odontogenic tumor. J Craniofac Surg 27:1361–1366

    PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Johann ACBR, Caldeira PC, Caliari MV, Gomez RS, Aguiar MCF, Mesquita RA (2015) Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour. Med Oral Patol Oral Cir Bucal 20:e408–e412

    PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Kadlub N, Coudert A, Gatibelza ME, El Houmami N, Soufir N, Ruhin-Poncet B, L'Hermine AC, Berdal A, Vazquez MP, Descroix V, Picard A (2013) PTCH1 mutation and local aggressiveness of odontogenic keratocystic tumors in children: is there a relationship? Hum Pathol 44:1071–1078. https://doi.org/10.1016/j.humpath.2012.09.012

    Article  PubMed  PubMed Central  Google Scholar 

  73. 73.

    Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint HP, Rivera RS, Nakajima M, Naomoto Y, Nagai N (2007) Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor. J Oral Pathol Med 36:550–554

    PubMed  Article  PubMed Central  Google Scholar 

  74. 74.

    Kimi Κ, Kumamoto Η, Ooya Κ, Motegi Κ (2000) Analysis of apoptosis-related factors and apoptotic cells in lining epithelium of odontogenic keratocysts. Oral Med Pathol 5:35–40

    Article  Google Scholar 

  75. 75.

    Leite RB, Cavalcante RB, Nogueira RLM, Souza LB, Pereira Pinto L, Nonaka CFW (2017) Analysis of GLUT-1, GLUT-3, and angiogenic index in syndromic and non-syndromic keratocystic odontogenic tumors. Braz Oral Res 31:e34. https://doi.org/10.1590/1807-3107BOR-2017.vol31.0034

    Article  PubMed  PubMed Central  Google Scholar 

  76. 76.

    Leonardi R, Matthews JB, Caltabiano R, Greco M, Lombardo C, Loreto C, Santarelli A, Lo Muzio L (2010) MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts. Oral Dis 16:795–800. https://doi.org/10.1111/j.1601-0825.2010.01690.x

    Article  PubMed  PubMed Central  Google Scholar 

  77. 77.

    Leonardi R, Perrotta RE, Crimi S, Matthews JB, Barbato E, dos Santos JN, Rusu M, Bufo P, Bucci P, Pannone G (2015) Differential expression of TLR3 and TLR4 in keratocystic odontogenic tumor (KCOT): a comparative immunohistochemical study in primary, recurrent, and nevoid basal cell carcinoma syndrome (NBCCS)–associated lesions. J Craniomaxillofac Surg 43:733–737. https://doi.org/10.1016/j.jcms.2015.03.016

    Article  PubMed  PubMed Central  Google Scholar 

  78. 78.

    Li TJ, Browne RM, Matthews JB (1997) Immunocytochemical expression of parathyroid hormone related protein (PTHrP) in odontogenic jaw cysts. Br J Oral Maxillofac Surg 35:275–279

    PubMed  Article  PubMed Central  Google Scholar 

  79. 79.

    Li TJ, Browne RM, Matthews JB (1997) Immunocytochemical expression of growth factors by odontogenic jaw cysts. Mol Pathol 50:21–27. https://doi.org/10.1136/mp.50.1.21

    Article  PubMed  PubMed Central  Google Scholar 

  80. 80.

    Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB (1996) p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 25:249–255

    PubMed  Article  PubMed Central  Google Scholar 

  81. 81.

    Lombardi T, Odell EW, Morgan PR (1995) p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Arch Oral Biol 40:1081–1084

    PubMed  Article  PubMed Central  Google Scholar 

  82. 82.

    Malaguez GG, Munhoz EA, Rivero ERC, Rados PV, Oliveira MG (2020) Podoplanin expression in odontogenic keratocysts associated or not associated with nevoid basal cell carcinoma syndrome. Appl Immunohistochem Mol Morphol 28:513–517

    PubMed  Article  PubMed Central  Google Scholar 

  83. 83.

    Mascitti M, Togni L, Balercia A, Balercia P, Rubini C and Santarelli A (2020) p53-Family proteins in odontogenic cysts: an immunohistochemical study. Applied immunohistochemistry & molecular morphology : AIMM:369-375. doi: https://doi.org/10.1097/pai.0000000000000727

  84. 84.

    Mateus GCP, Lanza GHDSP, De Moura PHR, De Marigo HA, Horta MCR (2008) Cell proliferation and apoptosis in keratocystic odontogenic tumors. Med Oral Patol Oral Cir Bucal 13:e697–e702

    PubMed  PubMed Central  Google Scholar 

  85. 85.

    Meara JG, Pilch BZ, Shah SS, Cunningham MJ (2000) Cytokeratin expression in the odontogenic keratocyst. J Oral Maxillofac Surg 58:862–865

    PubMed  Article  PubMed Central  Google Scholar 

  86. 86.

    Mello LA, Figueiredo AL, Ramos EAG, Gurgel CAS, Martins MD, de Figueiredo CRLV, Cury PR, de Albuquerque Junior RLC, Ramalho LMP, Santos JN (2013) CD1a-positive Langerhans cells and their relationship with E-cadherin in ameloblastomas and keratocystic odontogenic tumors. J Oral Pathol Med 42:454–461

    PubMed  Article  PubMed Central  Google Scholar 

  87. 87.

    Mendes RA, Carvalho JF, van der Waal I (2011) Potential relevance of cyclooxygenase-2 expression in keratocystic odontogenic tumours—an immunohistochemical study. J Oral Pathol Med 40:497–503. https://doi.org/10.1111/j.1600-0714.2010.00997.x

    Article  PubMed  PubMed Central  Google Scholar 

  88. 88.

    Mendes RA, Carvalho JF, van der Waal I (2011) A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:333–339. https://doi.org/10.1016/j.tripleo.2010.10.004

    Article  PubMed  PubMed Central  Google Scholar 

  89. 89.

    Mendes RB, Dias RB, Figueiredo AL, Gurgel CA, Santana M, Melo LA, Trierveiler M, Cury PR, Leonardi R, Dos Santos JN (2017) Glypican-3 distinguishes aggressive from non-aggressive odontogenic tumors: a preliminary study. J Oral Pathol Med 46:297–300. https://doi.org/10.1111/jop.12501

    Article  PubMed  PubMed Central  Google Scholar 

  90. 90.

    Nonaka CFW, Cavalcante RB, Nogueira RLM, Souza LB, Pinto LP (2012) Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. Arch Oral Biol 57:230–237. https://doi.org/10.1016/j.archoralbio.2011.08.002

    Article  PubMed  PubMed Central  Google Scholar 

  91. 91.

    Ogden GR, Chisholm DM, Kiddie RA, Lane DP (1992) p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol 45:1007–1010

    PubMed  PubMed Central  Article  Google Scholar 

  92. 92.

    Pan S, Li TJ (2009) PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation? Oral Oncol 45:861–865

    PubMed  Article  PubMed Central  Google Scholar 

  93. 93.

    Pavelic B, Levanat S, Crnic I, Kobler P, Anic I, Manojlovic S, Sutalo J (2001) PTCH gene altered in dentigerous cysts. J Oral Pathol Med 30:569–576. https://doi.org/10.1034/j.1600-0714.2001.300911.x

    Article  PubMed  PubMed Central  Google Scholar 

  94. 94.

    de Assis Caldas Pereira F, Ramos EAG, Vidal MTA, Pinheiro ALB, Jurisic V, Sales CBS, Cury P, dos Santos JN (2012) Distribution of mast cells in benign odontogenic tumors. Tumour Biol 33:455–461. https://doi.org/10.1007/s13277-011-0274-2

    Article  PubMed  PubMed Central  Google Scholar 

  95. 95.

    Robinson PA, Markham AF, Schalkwijk J, High AS (1996) Increased elafin expression in cystic, dysplastic and neoplastic oral tissues. J Oral Pathol Med 25:135–139

    PubMed  Article  PubMed Central  Google Scholar 

  96. 96.

    Santos HBP, Morais EF, Cavalcante RB, Nogueira RLM, Nonaka CFW, Souza LB, Freitas RA (2020) Immunoexpression of DNA base excision repair and nucleotide excision repair proteins in ameloblastomas, syndromic and non-syndromic odontogenic keratocysts and dentigerous cysts. Arch Oral Biol 110:104627. https://doi.org/10.1016/j.archoralbio.2019.104627

    Article  PubMed  PubMed Central  Google Scholar 

  97. 97.

    Sarode SC, Sarode GS, Choudhary S, Patil S (2017) FAK is overexpressed in keratocystic odontogenic tumor: a preliminary study. J Oral Pathol Med 46:611–617

    PubMed  Article  PubMed Central  Google Scholar 

  98. 98.

    Shimada Y, Ki K, Kabasawa Y, Ki M, Omura K, Yamaguchi A, Sakamoto K (2013) Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features. PLoS One 8:1–11

    Google Scholar 

  99. 99.

    Shuler CF, Shriver BJ (1987) Identification of intermediate filament keratin proteins in parakeratinized odontogenic keratocysts—a preliminary study. Oral Surg Oral Med Oral Pathol 64:439–444. https://doi.org/10.1016/0030-4220(87)90149-6

    Article  PubMed  PubMed Central  Google Scholar 

  100. 100.

    Singh H, Nayar A, Raj A, Kumar P (2013) Are all odontogenic keratocysts keratocystic odontogenic tumors? Correlation between imaging features and epithelial cell proliferation. J Clin Imaging Sci 3:3

    PubMed  Article  PubMed Central  Google Scholar 

  101. 101.

    Vera-Sirera B, Forner-Navarro L, Vera-Sempere F (2015) NCAM (CD56) expression in keratin-producing odontogenic cysts: aberrant expression in KCOT. Head Face Med 11:3

    PubMed  PubMed Central  Article  Google Scholar 

  102. 102.

    Vera-Sirera B, Forner-Navarro L, Vera-Sempere F (2016) Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts. BMC Oral Health 16:32

    PubMed  PubMed Central  Article  Google Scholar 

  103. 103.

    Vered M, Peleg O, Taicher S, Buchner A (2009) The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med 38:597–604

    PubMed  Article  PubMed Central  Google Scholar 

  104. 104.

    Hirshberg A, Sherman S, Buchner A, Dayan D (1999) Collagen fibres in the wall of odontogenic keratocysts: a study with picrosirius red and polarizing microscopy. J Oral Pathol Med 28:410–412. https://doi.org/10.1111/j.1600-0714.1999.tb02112.x

    Article  PubMed  PubMed Central  Google Scholar 

  105. 105.

    Mendes RA, Carvalho JF, van der Waal I (2010) Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. Oral Oncol 46:219–225. https://doi.org/10.1016/j.oraloncology.2010.01.012

    Article  PubMed  PubMed Central  Google Scholar 

  106. 106.

    Meruvia-Pastor OE, Soh J, Schmidt EJ, Boughner JC, Xiao M, Jamniczky HA, Hallgrimsson B, Sensen CW (2011) Estimating cell count and distribution in labeled histological samples using incremental cell search. Int J Biomed Imaging 2011:874702–874716. https://doi.org/10.1155/2011/874702

    Article  PubMed  PubMed Central  Google Scholar 

  107. 107.

    Pons MN, Vivier H (2000) Biomass quantification by image analysis. Adv Biochem Eng Biotechnol 66:133–184. https://doi.org/10.1007/3-540-48773-5_5

    Article  PubMed  PubMed Central  Google Scholar 

  108. 108.

    Adams EJ, Green JA, Clark AH, Youngson JH (1999) Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 52:75–77. https://doi.org/10.1136/jcp.52.1.75

    Article  PubMed  PubMed Central  Google Scholar 

  109. 109.

    Taylor CR, Levenson RM (2006) Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II. Histopathology 49:411–424. https://doi.org/10.1111/j.1365-2559.2006.02513.x

    Article  PubMed  PubMed Central  Google Scholar 

  110. 110.

    Guo YY, Zhang JY, Li XF, Luo HY, Chen F, Li TJ (2013) PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review. PLoS One 8:e77305. https://doi.org/10.1371/journal.pone.0077305

    Article  PubMed  PubMed Central  Google Scholar 

  111. 111.

    Stojanov IJ, Schaefer IM, Menon RS, Wasman J, Gokozan HN, Garcia EP, Baur DA, Woo SB, Sholl LM (2020) Biallelic PTCH1 inactivation is a dominant genomic change in sporadic keratocystic odontogenic tumors. Am J Surg Pathol 44:553–560. https://doi.org/10.1097/PAS.0000000000001407

    Article  PubMed  PubMed Central  Google Scholar 

  112. 112.

    Maheswaran T, Ramesh V, Oza N, Panda A, Balamurali PD (2014) Keratin metaplasia in the epithelial lining of odontogenic cysts. J Pharm Bioallied Sci 6:S110–S112. https://doi.org/10.4103/0975-7406.137405

    Article  PubMed  PubMed Central  Google Scholar 

  113. 113.

    El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ and editors (2017) Odontogenic and maxillofacial bone tumours. Book title., Lyon, France: IARC

  114. 114.

    Gonzalez-Moles MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, Ayen A, Lenouvel D, Ruiz-Avila I, Ramos-Garcia P (2020) Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: a systematic review and a comprehensive meta-analysis. Oral Oncol 106:104688. https://doi.org/10.1016/j.oraloncology.2020.104688

    Article  PubMed  PubMed Central  Google Scholar 

  115. 115.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013

    Article  Google Scholar 

  116. 116.

    Seidal T, Balaton AJ, Battifora H (2001) Interpretation and quantification of immunostains. Am J Surg Pathol 25:1204–1207. https://doi.org/10.1097/00000478-200109000-00013

    Article  PubMed  PubMed Central  Google Scholar 

  117. 117.

    Heikinheimo K, Kurppa KJ, Laiho A, Peltonen S, Berdal A, Bouattour A, Ruhin B, Caton J, Thesleff I, Leivo I, Morgan PR (2015) Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res 94:101–111. https://doi.org/10.1177/0022034514556815

    Article  PubMed  PubMed Central  Google Scholar 

  118. 118.

    Hu S, Divaris K, Parker J, Padilla R, Murrah V, Wright JT (2016) Transcriptome variability in keratocystic odontogenic tumor suggests distinct molecular subtypes. Sci Rep 6:24236. https://doi.org/10.1038/srep24236

    Article  PubMed  PubMed Central  Google Scholar 

  119. 119.

    Jiang WP, Sima ZH, Wang HC, Zhang JY, Sun LS, Chen F, Li TJ (2014) Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis. Int J Oral Sci 6:31–38. https://doi.org/10.1038/ijos.2013.96

    Article  PubMed  PubMed Central  Google Scholar 

  120. 120.

    Diniz MG, Duarte-Andrade FF, Stussi F, Vitorio JG, Fonseca FP, Ramos Domingues R, Paes Leme AF, Gomes CC, Gomez RS (2020) Deregulation of desmosomal proteins and extracellular matrix proteases in odontogenic keratocyst. Oral Dis. https://doi.org/10.1111/odi.13598

Download references

Acknowledgements

The authors thank Dr. Apostolos Klinakis (Investigator-Professor Level, Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece) and Dr. Theodoros Rampias (Investigator-Assistant Professor Level, Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece) for the critical proofreading of the manuscript and their constructive comments.

Funding

This research is co-financed by Greece and the European Union (European Social Fund-ESF) through the Operational Programme «Human Resources Development, Education and Lifelong Learning» in the context of the project “Strengthening Human Resources Research Potential via Doctorate Research” (MIS-5000432), implemented by the State Scholarships Foundation (ΙΚΥ). This funding source supports the author Eleni-Marina Kalogirou and had no involvement in study design, in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the report for publication.

Author information

Affiliations

  1. Department of Oral Medicine and Pathology, Faculty of Dentistry, National and Kapodistrian University of Athens, Athens, Greece

    Eleni-Marina Kalogirou, Grigorios Thermos & Konstantinos I. Tosios

  2. Center of Systems Biology, Biomedical Research Foundation, Academy of Athens, Athens, Greece

    Vasileios Zogopoulos & Ioannis Michalopoulos

  3. Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece

    Spyros Foutadakis & Marios Agelopoulos

Authors
  1. Eleni-Marina Kalogirou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grigorios Thermos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vasileios Zogopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Spyros Foutadakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ioannis Michalopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marios Agelopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Konstantinos I. Tosios
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

E.M. Kalogirou and G. Thermos designed the study, performed the literature search and data analysis, and prepared, edited, and reviewed the paper. K.I. Tosios participated in study design and data analysis and prepared, edited, and reviewed the paper. V. Zogopoulos and I. Michalopoulos performed statistical analysis and prepared, edited, and reviewed the paper. M. Agelopoulos and S. Foutadakis prepared, edited, and reviewed the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Eleni-Marina Kalogirou.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(DOCX 3456 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kalogirou, EM., Thermos, G., Zogopoulos, V. et al. The immunohistochemical profile of basal cell nevus syndrome–associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis. Clin Oral Invest (2021). https://doi.org/10.1007/s00784-021-03877-w

Download citation

Keywords

  • Odontogenic keratocyst
  • Basal cell nevus syndrome
  • Nevoid basal cell carcinoma syndrome
  • Immunohistochemistry
  • Systematic review
  • Meta-analysis